Pharmacologic prevention of colonic neoplasms

Digestive Diseases

Volumn 14, Issue 2, 1996, Pages 119-128

  Eastwood, Gregory L ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Calcium; Colon cancer; Nonsteroidal anti inflammatory drugs (NSAIDs); Vitamins

Indexed keywords

CALCIUM; FISH OIL; NONSTEROID ANTIINFLAMMATORY AGENT; VITAMIN;

ANIMAL; CELL TRANSFORMATION; COLON TUMOR; HUMAN; INTESTINE MUCOSA; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; FISH OILS; HUMANS; INTESTINAL MUCOSA; VITAMINS;

EID: 0030097039     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171543     Document Type: Article

References (123)

1. Boring CC, Squires TS, Tong T, Montgomery S: Cancer statistics. 1994. CA Cancer J Clin 1994:44:7-26.
2. Winawer SJ. Flehinger BJ. Schotten-feld D, Miller DG: Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993:85:1311-1318.
3. Mandel JS. Bond JH. Church TR. Snover DC. Bradley GM. Schuman LM, Ederer F, for the Minnesota Colon Cancer Control Group: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993: 328:1365-1371.
4. Winawer SJ: Colorectal cancer screening comes of age. N Engl J Med 1993:328:1416-1417.
5. Selby JV. Friedman GD. Quesen-berry CP, Weiss NS: A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992:326:653-657.
6. Newcomb PA. Norfleet RG, Storer BE. Surawicz TS, Marcus PM: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992:84:1572-1575.
7. Muto T. Bussey HJR. Morson BC: The evolution of cancer of the colon and rectum. Cancer 1975:36:2251-2270.
8. Gilbertson VA, Nelms JM: The prevention of invasive cancer of the rectum. Cancer 1978:41:1137-1139.
9. Atkin WS, Morson BC, Cuzick J: Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992:326: 658-662.
10. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Wave J D, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Homsby-Lewis L, Gerdes H, Stewart ET. the National Polyp Study Workgroup: Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993:329:1977-1981.
11. Busel M. Lipkin M, Winawer S, Swaroop S. Friedman E: Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res 1986:46:5426-5430.
12. Lipkin M, Newmark H: Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med 1985:313: 1381-1383.
13. Rozen P. Fireman Z. Fine N. Wax Y. Rone E: Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer. Gut 1989:30:650-655.
14. Lans J. Jaszewski R, Arlow F. Tu-reaud J. Colarian J. Luk GD. Ma-jumdar APN: Supplemental calcium suppresses colonic mucosal ornithine decarboxylase activity in elderly patients with adenomatous polyps (abstract). Gastroenterology 1990:98:292.
15. Paganclli GM. Biasco G, Brandi G. Santucci R. Gizzi G. ViUani V, Cianci M, Miglioli M, Barbara L: Effect of vitamins A. C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas. J Natl Cancer Inst 1992:84: 47-51.
16. Bussey HJR. DcCrosse JJ. Deschner EE, Evers AA. Lesser ML. Morson BC. Ritchie SM, Thomson JPS, Wadsworth J: A randomized trial of ascorbic acid in polyposis coli. Cancer 1982:50:1434-1439.
17. Phillips RW. Willis SM. Luk G. Mehta R. Kikendall JW. Bown PE. Maydonovitch C. Wong RKH: The effect ofbcta-carotcncon rectal mucosal ornithine decarboxylase activity in patients with colon cancer (abstract). Gastroenterology 1991:100: 394.
18. Macrae FA. Hughes NR, Bhathal PS. Tay D, Sclbie L, Mac Pennon R: Dietary suppression of rectal epithelial cell proliferation (abstract). Gastroenterology 1991; 100:383.
19. Anti M. Marra G, Armelao F, Bar-loli GM, Ficarelli R, Pcrcesepe A. De Vitis I. Maria G, Sofo L. Rapac-cini GL. Gentolini N. Piccioni E. Miggiano G: Effect of ontega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. Gastroenterology 1992:103: 883-891.
20. Bartram H-P. Gostncr A. Schcp-pach W, Reddy BS, Rao CV. Dusel G, Richter F. Richter A, Kasper H: Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin Ei release in healthy subjects. Gastroenterology 1993: 105:1317-1322.
21. Anti M. Armelao F. Marra G. Perce-sepe A, Bartoli GM. Palozza P. Par-rclla P. Canctta C. Gentiloni N, DeVitis I Gasbarrini G: Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology 1994;107:1709-1718.
22. Pence BC, Buddingh F: Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D. Carcinogenesis (Lond) 1988:9:187-190.
23. Reshef R. Rozen P, Fireman Z, Fine N, Barzilai M. Shasha SM. Shkolnik T: Effect of calcium-enriched diet on the colonic epithelial hvperpro-lifcralion induced by N-mcthyl-N'-nitro-N-nitrosoguanidine in rats on a low calcium and fat diet. Cancer Res 1990:50:1764-1767.
24. Arlow FL, Walczak SM, Luk GD, Majumdar APN: Attenuation of azoxymethanc-induced colonic mucosal ornithine decarboxylase and tyrosine kinase activity by calcium in rats. Cancer Res 1989:49:5884-5888.
25. Newbcme PM, Supliakarn V: Preventive role of vitamin A in colon carcinogenesis in rats. Cancer 1977; 40:2553-2556.
26. Reddy BS. Hirota N: Effect of dietary ascorbic acid on 1,2-dimethyl-hydrazinc-induced colon cancer in rats. Fed Proc 1979:38:714.
27. Cook MG. McNamara P: Effect of dietary vitamin E on dimcthylhy-drazine-induced colonic tumors in mice. Cancer Res 1980:40:1329-1331.
28. Reddy BS. Maruyama H: Effect of dietary fish oil on azoxvmethane-induccd colon carcinogenesis in male F344 rats. Cancer Res 1986: 46:3367-3370.
29. Minoura T, Takata T, Sakaguchi M. Takada H. Yamamura M. Hioki K. Yamamoto M: Effect of dietary ei-cosapentaenoic acid on azoxymcth-ane-induced colon carcinogenesis in rats. Cancer Res 1988;48:4790-4794.
30. Reddy BS, Sugie S: Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-in-duced colon carcinogenesis in F344 rats. Cancer Res 1988:48:6642- 6647.
31. Nelson RL. failure JC. Andriano-poulos G, Souza G, Lands WE: A comparison of dietary fish oil and com oil in experimental colorectal carcinogenesis. Nutr Cancer 1988: 11:215-220.
32. Deschner EE, Lytle JS, Wong G, Ru-berto JF. Newmark HL: The effect of dietary omega-3 fatty acids (fish oil) on azoxymcthanol-induccd focal areas of dysplasia and colon tumor incidences. Cancer 1990:66: 2350-2356.
33. Reddy BS, Burill C, Rigotty J: Effect of diets high in omega-3 and omega-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res 1991;51: 487-491.
34. Cave WT Jr.: Dietary omega-3 polyunsaturated fatty acid effects on animal tumorigenesis. FASEB J 1991; 5:2160-2166.
35. Waddel RW, Ganser C.F, Cerise EJ, Loughry RW: Sulindac for polyposis of the colon. Am J Surg 1989:157: 175-179.
36. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M. Attali P: Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991:101: 635-639.
37. Winde G. Gumbinger HG. Osswald H. Kemper F. Bunte H: The NSAID sulindac reverses rectal adenomas in coleclomizcd patients with familial adenomatous polyposis: Clinical results of a dose finding study on rectal sulindac administration. Int J Colorectal Dis 1993;8:13-17.
38. Giardello FM, Hamilton SR, Krusli AJ, Piantodosi S, Hylind LM, Cela-no P, Booker SV, Rahj Robinson C, Offerhaus GJA: Treatment of colonic rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993:328:1313-1316.
39. Spagnesi MT, Tonelli F, Dolara P, Caderni G, Valanzano R, Anastasi A. Bianchini F: Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment. Gastroenterology 1994;106:362-366.
40. Thun MJ. Namboodiri MM. Heath CW Jr.: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991:325:1593-1596.
41. Giovannucci E. Rimm EB. Stamp-fer MJ, Colditz GA, Aschcrio A, Willett WC: Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 1994;121:241-246.
42. Peleg II. Maibach HT. Brown SH. Wilcox CM: Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch Intern Med 1994:154: 394-399.
43. Suh O, Metllin C, Petrelli NJ: Aspirin use, cancer, and polyps of the large bowel. Cancer 1993:72:1171-1177.
44. Greenberg ER, Baron JA, Freeman DH Jr. Mandel JS, Haile R: Reduced risk of large-bowel adenomas among aspirin users, t he Polyp Prevention Study Group. J Nall Cancer Inst 1993:85:912-916.
45. Logan RF, Little J. Hawtin PG. Hardcastle JD: Effect of aspirin and nonsteroidal anti-inflammatory drugs on colorectal adenomas: Case control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ 1993;307:285-289.
46. Eastwood GL: A review of gastrointestinal epithelial renewal and its relevance to the development of adenocarcinomas of the gastrointestinal tract. J Clin Gastroenterol 1995: in press.
47. Eastwood GL: Gastrointestinal epithelial renewal. Gastroenterology 1977;72:962-975.
48. Leblond CP. Walter BE: Renewal of cell populations. Physiol Rev 1956; 36:255-276.
49. Isbell GM, Hu P-J, Lynch P. Rou-bein L. Katz R, Cafferty S. Patel S, Wargovich MJ: A comparison of tri-tiated thymidinc-autoradiography and bromodeoxvuridine-immuno-pcroxidasc techniques for measuring epithelial proliferation in the human colon (abstract). Gastroenterology 1989:96:228.
50. Ohyama S, Yonemura Y, Miwa K, Miyazaki I, Sasaki T: Proliferation assay of human gastric remnant by bromodeoxyuridine and flow cytometry. Gastroenterology 1992: 103:789-793.
51. Hebv O: Role of polyamines in the control of cell proliferation and differentiation. Differentiation 1981: 19:1-20.
52. Garewal HS, Sampliner R, Gerner E, Steinbronn K, Alberts D, Kendall D: Ornithine decarboxylase activity in Barrett's esophagus: A potential marker for dysplasia. Gastroenterology 1988:94:819-821.
53. Yamada K. Yoshitake K. Sato M. Ahnen DJ: Proliferating cell nuclear antigen expression in normal, preneoplastic. and neoplastic colonic epithelium of the rat. Gastroenterology 1992:103:160-167.
54. Gray MR, Hall PA, Nash J, Ansari B. Lane DP, Kingsnorth AN: Epithelial proliferation in Barrett’s esophagus by proliferating nuclear antigen immunolocalization. Gastroenterology 1992; 103:1769-1776.
55. Kuwayama H. Eastwood GL: Light and electron microscopic and autoradiographic studies on N-methyl-N-amylnitrosaminc-induced rat esophageal carcinogenesis. Dig Dis Sci 1987:33:83-91.
56. Deschner EE, Tamura, K. Bralow SP: Sequential histopathologv and cell kinetic changes in rat pyloric mucosa during gastric carcinogenesis induced by N-mcthyl-N'-nitro-N-nitrosoguanidinc. J Natl Cancer Inst 1979:63:171-179.
57. Quimby GF. Eastwood GL: Effect of N-mcthyl-N-nitrosoguanidine on gastroduodenal epithelial proliferation in Wistar/Lewis rats. J Nall Cancer Inst 1981:66:331-337.
58. Thurnherr N. Deschner EE, Stone-hill EH, Lipkin M: Induction of adenocarcinomas of the colon in mice by weekly injections of 1.2-dimeth-vlhydrazine. Cancer Res 1973:33: 940-945.
59. Richards TC: Early changes in the dynamics of crypt cell populations in mouse colon following administration of 1,2-dimethylhvdrazine. Cancer Res 1977:37:1680-1685.
60. Schwartz B. Avivl C. Lamprecht SA: Isolation and characterization of normal and neoplastic colonic epithelial cell populations. Gastroenterology 1991:100:692-702.
61. Herbst JJ. Berenson MM, McClos-key DW. Wiser WC: Cell proliferation in esophageal columnar epithelium (Barret’s esophagus). Gastroenterology 1978:75:683-687.
62. Pellish LJ. Hermos JA. Eastwood GL: Cell proliferation in three types of Barret’s epithelium. Gut 1980;21: 26-31.
63. Winawer SJ. Lipkin M: Cell proliferation kinetics in the gastrointestinal tract of man. IV. Cell renewal in the intestinalized gastric mucosa. J Natl Cancer Inst 1969:42:9-17.
64. Lipkin M, Correa P, Mikol YB, Higgins PJ, Cucllo C, Zarama G, Fon-tham E, Zavala D: Proliferative and antigenic modifications in epithelial cells in chronic atrophic gastritis. J Nall Cancer Inst 1985:75:613-619.
65. Bell B. Almy TP. Lipkin M: Cell proliferation kinetics in the gastrointestinal tract of man. III. Cell renewal in esophagus, stomach, and jejunum of a patient with treated pernicious anemia. J Natl Cancer Inst 1967:38:615-623.
66. Hansen OH, Larsen JK. Svendsen LB: Changes in gastric mucosal cell proliferation after antrectomy or vagotomy in man. Scand J Gastroenterol 1978:13:947-952.
67. Assad RT, Eastwood GL: Epithelial proliferation in human fundic mucosa after antrectomy and vagotomy. Gastroenterology 1980:79:807-811.
68. Bleiberg H, Mainguet P, Galand P, Chretien J, Dupont-Mairesse N: Cell renewal in the human rectum: In vitro autoradiographic study on active ulcerative colitis. Gastroenterology 1970:58:851-855.
69. Eastwood GL. Trier JS: Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis. Gastroenterology 1973;64:383-390.
70. Serafini EP. Kirk AP, Chambers TJ: Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut 1981:22:648-652.
71. Deschner EE. Winawer SJ. Katz S. Kahn E: Proliferative defects in ulcerative colitis patients. Cancer Invest 1983;1:41-47.
72. Lightdale C, Lipkin M, Deschner E: In vivo measurements in familial polyposis: Kinetics and location of proliferating cells in colonic adenomas. Cancer Res 1982:42:4280- 4283.
73. Bleiberg H. Mainguet P. Galand P: Cell renewal in familial polyposis: Comparison between polyps and adjacent healthy mucosa. Gastroenterology 1972;63:240-245.
74. Lipkin M. Enker WF. Winawer SJ: Tritiatcd-thymidinc labeling of rectal epithelial cells in’non-prep’ biopsies of individuals at increased risk for colonic neoplasia. Cancer Lett 1987:37:153-161.
75. Terpstra OT, van Blankenstein M. Dees J. Eilers GAM: Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987;92:704-708.
76. Garland C. Shekelle RB. Barrett-Connor E, Criqui MH. Rossof AH, Paul O: Dietary vitamin D and calcium and risk of colorectal cancer: A 19-ycar prospective study in man. Lancet 1985;i:307-309.
77. Heilbrun LK. Hankin JH. Nomura AMY. Stemmermann GN: Colon cancer and dietary fat, phosphorus, and calcium in Hawaiian-Japanese men. Am J Clin N'utr 1986;43:306-309.
78. Yuspa SH, Kilkenny AE. Steinert PM. Roop DR: Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentration in vitro. J Cell Biol 1989; 109:1207-1217.
79. Babcock MS. Marino MR. Gunning WT III, Stoner GD: Clonal growth and serial propagation of rat esophageal epithelial cells. In Vitro 1983; 19:403-415.
80. Whitfield JF, MacManus JP. Sikors-ka M. Tsang BK: The regulation of cell proliferation by calcium and cyclic AMP. Mol Cell Biochem 1979; 27:155-179.
81. Gregoire RC. Stern HS. Yeung KS. Stadler J, Langley S. Furrcr R, Bruce WR: Effect of calcium supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut 1989;30:376-382.
82. Kleibeuker JH, Welberg JW, Mulder NH, van der Meer R, Cats A, Limburg AJ, Kreumer WM, Har-donk MJ, de Vries EG: Epithelial cell proliferation in the sigmoid colon of patients with adenomatous polyps increases during oral calcium supplementation. BrJ Cancer 1993; 67:500-503.
83. Armilage NC. Rooney PS. Gifford KA. Clarke PA, Hardcastle JD: The effect of calcium supplements on rectal mucosal proliferation. Br J Cancer 1995:71:186-190.
84. Newmark HL. Lipkin M: Calcium, vitamin D. and colon cancer. Cancer Res 1992;52(suppl):2067-2070.
85. Newmark HL: Calcium in cellular functions. Triangle 1989:28 (suppl 1):3-13.
86. Rasmussen H: The calcium messenger system. N Engl J Med 1986:314: 1094-1101.1164-1170.
87. Wargovich MJ. Eng VWS. Newmark HL: Calcium inhibits the damaging and compensating proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett 1984:23:253-258.
88. Wargovich MJ. Eng VWS, Newmark HL, Bruce WR: Calcium ameliorates the toxic effect of deoxy-cholic acid on colonic epithelium. Carcinogenesis (Lond) 1983,4: 1205-1207.
89. Bird RP, Schneider R, Stamp D, Bruce WR: Effect of dietary calcium and cholic acid on the proliferative indices of murine colonic epithelium. Carcinogenesis (Lond) 1986;7: 1657-1661.
90. Lapre JA, De Vries HT, Kieman JH, Van der Meer R: The antiproliferative effect of dietary calcium on colonic epithelium is mediated by luminal surfactants and dependent on the type of dietary fat. Cancer Res 1993;53:784-789.
91. Sleinmctz KA. Potter JD: Vegetables. fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991:2: 325-327.
92. Byers T. Perry G: Dietary' carotenes, vitamin C. and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr 1992; 12:139-159.
93. Block G: Vitamin C and cancer prevention: The epidemiologic evidence. Am J Clin Nutr 1991:53 (suppl):207-282.
94. Bostick RM. Potter JD. McKenzie DR. Sellers TA, Kushi LH, Stein-metz KA. Folsom AR: Reduced risk of colon cancer with high intake of vitamin E: The Iowa Women’s Health Study. Cancer Res 1993;53: 4230-4237.
95. Knckt P: Role of vitamin E in the prophylaxis of cancer. Ann Med 1991:23:3-12.
96. Longnecker MP, Martin-Moreno J-M, Knekt P, Nomura AMY, Scho-ber SE, Stakelin HB. Wald NJ, Gey KF, Willett WC: Scrum alpha-to-copherol concentration in relation to subsequent colorectal cancer: Pooled data from five cohorts. J Natl Cancer Inst 1992;84:430-435.
97. van Poppcl G: Carotcnoids and cancer: An update with emphasison human intervention studies. Eur J Cancer 1993;29:1335-1344.
98. DcCosse JJ, Miller HH, Lesser ML: Effect of wheal fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis. J Natl Cancer Inst 1989;81: 1290-1297.
99. Roncucci L. Di Donato P. Carati L, Ferrari A. Pcrini M, Bertolini G, Bedogni G. Paris B. Svanoni F, Gi-rola M. Ponz de Leon M: Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dis Colon Rectum 1993:36:227-234.
100. McKcown-Eyssen G, Holloway C, Jazmaji V, Bright-See E, Dion P, Bruce WR: A randomized triai of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 1988:48:4701-4705.
101. Greenberg ER, Baron JA, Toste-son TD, Freeman DH Jr., Beck GJ, Bond JH, Colacchio TA, Coller JA, Frankl HD. Haile RW. Man-del JS, Nierenberg DW, Rothstein R, Snover DC, Stevens MM, Summers RW, van Stolk RU. for the Polyp Prevention Study Group: A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994:331:141-147.
102. Zhao LP, Kushi LH, Klein RD, Prentice RL: Quantitative review of studies of dietary fat and rat colon carcinoma. Nutr Cancer 1991:15:169-177.
103. Reddy BS: Dietary fat and colon cancer: Animal model studies. Lipids 1992;27:807-813.
104. Nigro ND, Singh DV. Campbell RL. Parks MS: Effect of dietary beef fat on intestinal tumor formation by azoxymethane in rats. J Natl Cancer Inst 1975:54:439-442.
105. Bull AW, Soullier BK, Wilson PS, Hayden MT, Nigro ND: Promotion of azoxymethane-induced intestinal cancer by high-fat diet in rats. Cancer Res 1979:39:4956-4959.
106. Reddy BS, Maemura Y: Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: Influence of amount and source of dietary fat. J Natl Cancer Inst 1984;72:745-750.
107. Sakaguchi M. Hiramatsu Y. Ta-kada H. Yamantura M. Hioki K. Saito K. Yamamoto M: Effect of dietary' unsaturatcd and saturated fats on azoxymethane-induced colon carcinogenesis in rats. Cancer Res 1984;44:1472-1477.
108. Reddy BS. Maruyama H: Effect of different levels of dietary com oil and lard during the initiation phase of colon carcinogenesis in F344 rats. J Natl Cancer Inst 1986: 77:815-822.
109. Blot WJ. Lanier A. Fraumeni JF. Bender TR: Cancer mortality among Alaskan natives. J Natl Cancer Inst 1975:55:547-554.
110. Band HO. Dycrberg J. Hjorne N: The composition of food consumed by Greenland Eskimos. Acta MedScand 1976:200:69-73.
111. Willett WC, Stampfcr MJ, Colditz GA, Rosner BA. Speizer FE: Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990:323:1664-1672.
112. Rao CV, Reddy BS: Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis in male F344 rats. Carcinogenesis 1993:14: 1327-1333.
113. Lupulescu A: Enhancement of carcinogenesis by prostaglandins. Nature 1978:270:634-636.
114. Craven PA. Saito R. De Rubcrtis FR: Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium. J Clin Invest 1983:72: 1365-1375.
115. Uribe A. Rubio C. Johansson C: Cell kinetics of rat gastrointestinal mucosa. Autoradiographic study after treatment with 15(R) 15-methyl-prostaglandin E2. Stand J Gastroenterol 1986:21:246-252.
116. Uribe A. Johansson C, Rubio C: Cell proliferation of the rat gastrointestinal mucosa after treatment with E2 prostaglandins and indomcthacin. Digestion 1987:36: 238-245.
117. Svendsen LB, Jorgensen FS, Hansen OH, Johansen A, Horn T, Larsen JK: Influence of the prostaglandin El analogue rioprostil on the human gastric mucosa. Digestion 1987:37:29-34.
118. Niv Y. Fraser GM: Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 1994:107:854-857.
119. Ladenheim J. Garcia G, Titzcr D. Herzcnbcrg H, Lavori P. Edson R. Omarv MB: Effect of sulindac on sporadic colonic polyps. Gastroenterology 1995:108:1083-1087.
120. Paganini-Hill A. Hsu G. Ross RK. Henderson BE: Aspirin use and incidence of largc-bowel cancer in a California retirement community. J Natl Cancer Inst 1991:83:1182-1183.
121. Yeomans ND. St John DJD. de Boer WGRM: Regeneration of gastric mucosa after aspirin-induced injury in the rat. Am J Dig Dis 1973:18:773-780.
122. Eastwood GL. Quimby GF: Effect of chronic aspirin ingestion on epithelial proliferation in rat fundus, antrum, and duodenum. Gastroenterology 1982:82:852-856.
123. Lynch NR. Castes M. Astoin M. Salomon JC: Mechanism of inhibition of tumour growth by aspirin and indomcthacin. Br J Cancer 1978:38:503-512